avanbulin

Avanbulin is a potent inhibitor of tubulin polymerization with antitumor activity. It elicits a unique microtubule (MT) phenotype, distinct from colchicine, paclitaxel, and vinblastine has broad in vitro anti-proliferative activity against a diverse range

Lisavanbulin (BAL-101553) is a prodrug of Avanbulin (BAL 27862), a microtubule-targeting agent. It exhibits antitumor activity, particularly effective against tumors with high expression of end-binding protein 1.

Lisavanbulin (BAL-101553) dihydrochloride serves as a precursor to the microtubule-targeting agent Avanbulin (BAL 27862). Lisavanbulin dihydrochloride exhibits antitumor activity, particularly in tumors that express high levels of end-binding protein 1.